Allarity Therapeutics, Inc. · NASDAQ:ALLR

Allarity Therapeutics, Inc. financial statements

Allarity Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue320.0K00000120.0K1.46M1.46M143.3K
Cost of revenue9.00K37.0K120.0K106.0K86.0K5.08M2.22M
Gross profit320.0K-9.00K-37.0K-2.27M-106.0K-86.0K120.0K-3.62M-761.5K143.3K
Research and development6.60M6.10M7.10M6.93M14.2M4.22M6.37M
Selling, general and administrative6.32M11.4M10.0M9.96M12.4M4.10M3.87M
Operating income-12.6M-27.2M-17.1M-34.5M-26.6M-8.32M-17.6M-4.98M-3.84M-4.49M
Depreciation and amortization13.0K9.00K37.0K60.0K106.0K46.0K51.0K32.5K8.70K278.2K
EBITDA-12.6M-27.2M-17.1M-34.4M-26.4M-8.27M-17.6M-4.95M-3.83M-4.21M
Interest expense185.0K653.0K498.0K223.0K99.0K93.0K3.31M233.2K2.42K43.7K
Income before tax-11.2M-24.9M-11.8M-17.6M-26.5M-6.42M-19.0M-3.46M-4.99M-4.45M
Income tax0-381.0K83.0K-1.52M133.0K198.0K-4.58M-1.07M-95.1K-766.9K
Net income-11.2M-24.5M-11.9M-16.1M-26.6M-6.62M-14.3M-2.29M-4.90M-3.68M
Earnings per share, basic-0.78-15.65-6,031.31-3,093.42-4.19-2.03
Earnings per share, diluted-10.26-3,093.42-4.19

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents14.7M19.5M166.0K2.03M19.6M298.0K1.52M237.4K536.0K2.07M
Short-term investments72.0K0350.0K
Receivables895.0K2.23M946.0K871.0K1.34M1.12M1.66M10.8M407.7K2.31K
Inventory-1.34M-2.00K168.9K34.7K
Current assets17.9M22.3M1.97M4.97M21.4M1.72M3.34M2.21M1.31M4.37M
Property, plant and equipment330.0K309.0K20.0K21.0K8.00K21.0K2.92M363.0K135.0K
Goodwill1.91M
Total assets18.3M22.6M11.9M14.5M49.6M33.4M31.6M38.6M2.09M6.54M
Accounts payable4.28M4.18M8.42M6.25M698.0K2.12M2.18M1.94M472.4K1.27M
Current liabilities8.43M10.8M14.2M11.2M20.7M5.53M4.72M5.43M1.70M1.34M
Long-term debt1.08M979.0K880.0K
Total debt1.40M1.35M2.69M2.64M1.09M1.79M963.0K2.90M
Total liabilities8.43M10.8M14.6M12.7M30.8M8.96M10.7M10.7M1.70M1.34M
Shareholders' equity9.83M11.8M-2.75M-113.0K18.2M24.4M20.9M27.9M394.0K5.20M
Shares outstanding16.1M7.30M9.81K11.4K8.10M4.25M4444

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-14.8M-17.4M-12.7M-16.8M-14.9M-7.25M-10.1M-4.24M-1.34M-3.98M
Capital spending-8.00K-298.0K0-18.0K-18.0K-3.00K-8.00K-5.68K-37.0K-77.8K
Free cash flow-14.8M-17.6M-12.7M-16.8M-15.1M-7.25M-10.1M-4.24M-1.34M-4.06M
Cash from investing-8.00K-298.0K0791.0K1.00M-3.00K229.0K1.51M-128.0K-178.7K
Cash from financing10.6M36.8M11.0M-1.31M33.8M6.03M11.2M2.42M1.16M4.31M
Dividends paid-11.0M-1.51M
Share buybacks-3.19M0-6.65M-1.51M0
Change in cash-4.18M19.1M-1.75M-17.3M19.9M-1.22M1.29M-298.6K-1.54M2.07M